000 | 01947 a2200553 4500 | ||
---|---|---|---|
005 | 20250516225354.0 | ||
264 | 0 | _c20150615 | |
008 | 201506s 0 0 eng d | ||
022 | _a1432-1106 | ||
024 | 7 |
_a10.1007/s00221-014-4052-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOmidbakhsh, Rana | |
245 | 0 | 0 |
_aFingolimod affects gene expression profile associated with LPS-induced memory impairment. _h[electronic resource] |
260 |
_bExperimental brain research _cNov 2014 |
||
300 |
_a3687-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 |
_aDark Adaptation _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Administration Routes |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFingolimod Hydrochloride |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory Disorders _xchemically induced |
650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
650 | 0 | 4 |
_aPropylene Glycols _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSphingosine _xanalogs & derivatives |
650 | 0 | 4 | _aTranscriptome |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
700 | 1 | _aRajabli, Banafshe | |
700 | 1 | _aNasoohi, Sanaz | |
700 | 1 | _aKhallaghi, Behzad | |
700 | 1 | _aMohamed, Zahurin | |
700 | 1 | _aNaidu, Murali | |
700 | 1 | _aAhmadiani, Abolhassan | |
700 | 1 | _aDargahi, Leila | |
773 | 0 |
_tExperimental brain research _gvol. 232 _gno. 11 _gp. 3687-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00221-014-4052-4 _zAvailable from publisher's website |
999 |
_c24075387 _d24075387 |